Heartflow, Inc. (NASDAQ:HTFL) Stock Has Average Price Target of $48.62 According to Analysts

Heartflow, Inc. (NASDAQ:HTFL) has been given a consensus recommendation of “Moderate Buy” by the twelve brokerages that are covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a sell rating, two have given a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company. The average 1-year price objective among brokers that have issued a report on the stock in the last year is $48.62.

HTFL has been the subject of several analyst reports. Morgan Stanley raised their target price on Heartflow from $35.00 to $40.00 and gave the stock an “equal weight” rating in a research report on Friday, August 14th. UBS Group started coverage on Heartflow in a research note on Wednesday, September 9th. They set a “neutral” rating and a $55.00 price objective for the company. Robert W. Baird set a $45.00 price objective on Heartflow in a report on Friday, August 14th. Wells Fargo & Company boosted their target price on shares of Heartflow from $37.00 to $39.00 and gave the company an “overweight” rating in a research note on Friday, August 14th. Finally, Benchmark reaffirmed a “buy” rating on shares of Heartflow in a report on Friday, August 14th.

Heartflow Stock Performance

HTFL opened at $54.40 on Friday. Heartflow has a 1 year low of $20.13 and a 1 year high of $60.56. The stock’s 50 day simple moving average is $51.00 and its 200-day simple moving average is $34.37.

Heartflow (NASDAQ:HTFL) last posted its quarterly earnings results on Thursday, August 13th. The company reported ($0.07) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.22) by $0.15. The firm had revenue of $64.08 million for the quarter. Heartflow had a negative net margin of 55.82% and a negative return on equity of 23.52%. The company’s quarterly revenue was up 47.7% compared to the same quarter last year. As a group, equities analysts expect that Heartflow will post -0.75 earnings per share for the current year.

Insider Buying and Selling at Heartflow

In other news, CFO Vikram Verghese sold 29,714 shares of Heartflow stock in a transaction that occurred on Friday, September 11th. The shares were sold at an average price of $50.06, for a total value of $1,487,482.84. Following the completion of the transaction, the chief financial officer owned 184,789 shares in the company, valued at approximately $9,250,537.34. The trade was a 13.85% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO John Farquhar sold 38,900 shares of Heartflow stock in a transaction that occurred on Monday, October 12th. The shares were sold at an average price of $49.57, for a total transaction of $1,928,273.00. Following the completion of the transaction, the chief executive officer owned 283,014 shares of the company’s stock, valued at $14,029,003.98. This trade represents a 12.08% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 328,038 shares of company stock worth $15,490,354 over the last ninety days. Corporate insiders own 7.70% of the company’s stock.

Hedge Funds Weigh In On Heartflow

Several institutional investors have recently bought and sold shares of the business. GAMMA Investing LLC raised its holdings in shares of Heartflow by 75.1% during the 3rd quarter. GAMMA Investing LLC now owns 641 shares of the company’s stock worth $32,000 after buying an additional 275 shares in the last quarter. IFP Advisors Inc boosted its stake in Heartflow by 844.7% in the third quarter. IFP Advisors Inc now owns 803 shares of the company’s stock valued at $40,000 after buying an additional 718 shares in the last quarter. Integrated Wealth Concepts LLC acquired a new stake in Heartflow in the second quarter valued at about $53,000. Essential Partners LLC bought a new position in Heartflow in the first quarter valued at about $57,000. Finally, Sterling Capital Management LLC grew its position in Heartflow by 797.9% in the third quarter. Sterling Capital Management LLC now owns 2,532 shares of the company’s stock valued at $126,000 after acquiring an additional 2,250 shares during the last quarter.

Heartflow Company Profile

Heartflow, Inc is a medical technology company that develops artificial intelligence-based tools to help physicians diagnose and manage coronary artery disease. Its platform uses data from coronary computed tomography angiography (CCTA) scans to create personalized, three-dimensional models of a patient’s coronary arteries and provide noninvasive assessments of blood flow and disease.

The company’s products include Heartflow Analysis, which provides fractional flow reserve computed tomography (FFR-CT) evaluations to help identify potentially significant blockages, as well as tools for assessing coronary plaque and planning treatment.